|
Authors are invited to submit scientific abstracts to be considered for presentation at the 8th International Symposium on Preimplantation Genetic Diagnosis. The material submitted should be unpublished, original and not have been presented in any other meeting.
Abstracts submitted for oral or poster presentation will be evaluated by the Scientific Committee. Once an abstract is accepted, the Committee will decide whether it is to be presented as an oral communication or as a Poster.
Oral Presentation:
Each presentation, to be given by the author, should last no more than 7 minutes and will be followed by a 3-minute discussion period. Authors will be informed of the day and time of each oral presentation in the letter of acceptance of their abstract.
Poster Presentation:
Authors of those abstracts accepted for poster presentation will be notified of the day and time of their poster session. During the poster session, one of the authors must be available at the specified times to answer questions from attendees.
Information about the size and format of the posters will be given to authors in their letter of acceptance.
GENERAL RULES
Abstracts received after this deadline will not be considered. The name of the presenting author should be indicated using bold font type. Authors, whose abstract have been accepted, must register for the Congress. Failure to do so will result in exclusion from the Congress Programme.
All abstracts must be submitted through the Congress online abstract submission system. Abstracts can not be submitted in paper form. Details can be found on the Congress Web site: www.bocemtium.com/pgdis2008. The online submission system will provide the appropriate fields required to submit abstracts.
Notification
Presenting authors will be notified regarding the acceptance and/or rejection of their submissions. (ESTIMATED DATE: February 29th, 2008). Instructions for oral and poster presentations will be included with this correspondence.
All submitted abstracts will be sent to an International Panel of Reviewers. The reviewers' decision is final and not open to appeal. Submission of an abstract indicates acceptance of and compliance with the abstract submission rules, the scientific validity of the presentation, and that all authors have read and approved the abstract and its contents. By submitting an abstract, the authors affirm that the work was conducted in accordance with current ethical standards and regulations in biomedical research. Failure to adhere to these standards will result in rejection of the abstract. The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission to the Secretariat.
With each submission, the presenting author will be the one who must include his/her address, telephone and fax numbers, and an e-mail address. This information will be used for correspondence regarding the receipt and acceptance of the abstract.
Abstracts requirements:
All abstracts must be submitted in English in a structured format which includes the following:
Title: Use a concise title that indicates the content of the abstract. The complete title should be capitalized. Do not use abbreviations in the title.
Authors: Surnames and initials for every author must be provided (i.e. Jones, B.; Smith, J.; and Simpson, A.). Do not include degrees or titles. An author’s name appearing on more than one abstract must be identical in each case.
Affiliations: Each author should be listed by institution, city, state/province and country. Do not include department, division, laboratory, etc. In abstracts where the authors have different affiliations, please indicate for each author the number of the corresponding affiliation.
Text: It should not exceed 400 words. Abstracts will be reproduced exactly as submitted and will not be edited in any way. Abbreviations should be kept to a minimum. Use of standard abbreviations is acceptable. Place special or unusual abbreviations in parentheses after the full term for the first time it appears. Linguistic accuracy is the responsibility of the authors. Drug products mentioned in the abstract should be identified by their non-proprietary names only. Do not capitalize non-proprietary names.
The key headings are as follows:
Objective: An introductory statement concisely indicating the purpose of the study.
Design & Method: Brief description of the study and the methods used, including statistical evaluation.
Results: A summary confirming or refuting the hypothesis, supported by statistics, if appropriate.
Conclusion: Based on the results as they appear in the abstract.
Key words. Up to three key words that summarize the contents of the abstracts can be entered and will be used for indexing the Abstract Book.
Abstracts stating that “results will be presented or discussed” are considered uninformative and may be subject to rejection.
Publication
Please note that all accepted abstracts will be published in a supplement to Reproductive BioMedicine online (issue to be determined).
Please avoid problems by checking your abstract carefully before sending it. No modifications can be made after submission.
Topics
Please indicate in the appropriate box the topic classification to which your abstract belongs. The Scientific Committee will attempt to respect the author’s option regarding their self-assignment to a special topic, but it reserves the right to change the allocation in order to achieve a well-balanced scientific program.
| 1. |
Alternative methods for embryo selection |
| 2. |
Diagnostic techniques |
| 3. |
Embryo Biopsy |
| 4. |
Embryo Development |
| 5. |
Implantation |
| 6. |
Mitochondrial Genetics |
| 7. |
PGD & Aneuploidy |
| 8. |
PGD & Genetic diseases |
| 9. |
PGD & HLA |
| 10. |
PGD & Translocations |
| 11. |
PGD / ART Data & Safety |
| 12. |
Prenatal diagnosis |
| 13. |
Stem Cells |
|